Health and Human Services Secretary Robert F. Kennedy Jr. attracted notice — and in some quarters, outrage — for remarks about autism, a topic he’s clashed with scientists about for years. Kennedy held an April 16 press conference pegged to a new Centers for Disease Control and Prevention report that found the prevalence of autism rising to 1 in 31 among 8-year-olds, the…
Rhythm Pharmaceuticals drug Imcivree met the body mass index reduction goals of a Phase 3 test in hypothalamic obesity, an acquired form of obesity stemming from dysregulation of the MC4R pathway in the hypothalamus. The engineered peptide drug is already approved for two genetically driven types of obesity. The post Rhythm Pharma Drug Lowers BMI…
C3HIE will be adding more than 20 hospitals to its network and expanding the HIE’s reach into rural healthcare communities in Texas
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
This policy watch provides an update on the latest trends in children’s routine vaccination and exemption rates and discusses how these trends could be impacted by the administration change.
[Sponsored] Mobile IV therapy brings hydration and wellness straight to your door. Compare top providers, including Mountain Rocky IV Medics, and find the right fit for your health needs. The post On-Demand Relief: What IV Therapy Company Offers the Fastest Service? appeared first on MedCity News.
By MIKE MAGEE It has been a collision of past, present and future this week in the wake of Trump’s victory on November 6, 2024. The country, both for and against, has been unusually quiet. It is unclear whether this is in recognition of political exhaustion, or the desire of victors to be “good winners”…
This stark reality raises an urgent question for health system executives: why aren’t patients engaging with these online tools, and how can we fix it? The post The Truth About Portals: Why Is Patient Usage so Low? appeared first on MedCity News.
On Tuesday (11 March 2025) the European Commission presented the draft of its new Critical Medicines Act (CMA). The Science Media Centre España writes that the CMA’s objective is: …to address the serious shortage of medicines and healthcare products, reduce external dependence on critical medicines and ingredients — especially from Asia — and guarantee the…
BenevolentAI said it will still develop its internally discovered drugs, but will now seek partners for them earlier in their development. Going forward, BenevolentAI will focus on making its AI technologies available to support the drug R&D efforts of its partners. The post AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio…